v3.26.1
Reconciliation of Financial Statements to Form 5500 (Tables)
12 Months Ended
Dec. 31, 2025
Pfizer Savings Plan  
EBP, Reconciliation of Financial Statement to Form 5500 [Line Items]  
EBP, Reconciliation of Financial Statement to Form 5500
The following is a reconciliation of net assets available for plan benefits per the financial statements to the Form 5500:
December 31,
(THOUSANDS OF DOLLARS)
20252024
Net assets available for plan benefits per the financial statements$24,197,074 $22,067,627 
Adjustment of T. Rowe Price Stable Value Fund from contract value to fair value(42,289)(85,505)
Amounts allocated to withdrawing participants(2,970)(5,360)
Deemed distributions(3,465)(3,682)
Net assets available for plan benefits per Form 5500$24,148,350 $21,973,080 
The following is a reconciliation of benefits paid, including rollovers, to participants per the financial statements to the Form 5500:
(THOUSANDS OF DOLLARS)
Year Ended December 31, 2025
Benefits paid to participants, including rollovers, per the financial statements$2,551,092 
Amounts allocated to withdrawing participants and deemed distributions at end of year
6,435 
Amounts allocated to withdrawing participants and deemed distributions at beginning of year
(9,042)
Benefits paid to participants, including rollovers, per Form 5500$2,548,485 
The following is a reconciliation of net appreciation in investments per the financial statements to the Form 5500:
(THOUSANDS OF DOLLARS)
Year Ended December 31, 2025
Net appreciation in investments per the financial statements
$3,274,729 
Adjustment of T. Rowe Price Stable Value Fund from contract value to fair value at end of year
(42,289)
Adjustment of T. Rowe Price Stable Value Fund from contract value to fair value at beginning of year
85,505 
Net appreciation in investments per Form 5500
$3,317,945